Trader Talk With Art Cashin 3.15.10
Airtime: Mon. Mar. 15 2010 |
Art Cashin, head of floor operations at UBS, has the buzz from the NYSE.
Airtime: Mon. Mar. 15 2010 |
Art Cashin, head of floor operations at UBS, has the buzz from the NYSE.
Insight on financial reform, the Volcker rule and derivatives legislation, with Bill Isaac, former FDIC chief and Paul Volcker, former Federal Reserve chairman.
Study Identifies Heart Risks in Glaxo’s Avandia. Dr. Steven Nissen, of the Cleveland Clinic, authored a controversial study identifying heart risks in GlaxoSmithKline’s Avandia diabetes drug. He talks to CNBC’s Mike Huckman.
Discussing whether the housing market will continue its rebound, Robert Shiller, Yale economics professor.
“The big risk is that there will be a downturn in markets that could impact the bond, the equity and the credit markets,” Nouriel Roubini, chairman of RGEMonitor.com, told CNBC when discussing the economic outlook Friday.
Parsing the jobs numbers, with CNBC’s Hampton Pearson; David Malpass, Encima Global president; Mark Zandi, Moody’s Economy.com chief economist; Andy Serwer, Fortune managing editor; Robert Barbera ITG chief economist; and CNBC’s Carl Quintanilla, Steve Liesman, Rick Santelli & Becky Quick.
Regaining control in spending, with Sam Zell, Equity Group Investments chairman.